EQS-News: Equity (NAV) increases by almost EUR 27 million to EUR 277.9 million, corresponding to EUR 64.90 per share. EBIT increases by EUR 2.75 million to EUR 33.0 million. The equity ratio rises to 95.5%.
|
EQS-News: MPH Health Care AG
/ Key word(s): Preliminary Results/Quarter Results
MPH Health Care AG publishes preliminary figures for the 2024 financial year: Equity (net asset value) increases by almost EUR 27 million to EUR 277.9 million, corresponding to EUR 64.90 per share. EBIT increases by EUR 2.75 million to EUR 33.0 million. The equity ratio rises to 95.5%. Berlin, 30th April 2025 - MPH Health Care AG (ISIN: DE000A289V03) announces the preliminary IFRS consolidated result for the 2024 financial year. Accordingly, equity increased by 10.7% from EUR 251.0 million to EUR 277.9 million. The net asset value (NAV) per share rose from EUR 58.62 (31 December 2023) to EUR 64.90 as of 31 December 2024. In the 2024 financial year, preliminary EBIT increased by 9.1% to EUR 33.0 million (previous year: EUR 30.2 million). The IFRS net profit for the year rose from EUR 29.5 million to EUR 32.0 million. As of 31 December 2024, equity increased by EUR 26.9 million to EUR 277.9 million (previous year: EUR 251.0 million). The equity ratio rose from 94.2% to 95.5% and remains at a very high level. MPH AG is an investment company whose investments are recognised as financial assets under the balance sheet item "Financial assets" and are measured at “fair value through profit or loss” at the balance sheet date. The net profit for the year is mainly the result of the fair value measurement of the listed investments held as of the balance sheet date, which result from the higher market prices of the investments compared to the previous year's balance sheet date. „Despite the current trade disputes with the USA and the ongoing conflict situation in Ukraine, we are confident about developments in 2025. The M1-Group plans to systematically continue its profitable growth by further expanding national and international specialist centres. By 2029, annual sales of EUR 200 to 300 million with an EBIT margin of at least 20% are targeted in the core ‘Beauty’ segment. With its vertically integrated investment portfolio, CR Energy AG is well positioned in the areas of ‘sustainable energy supply concepts’ and ‘quality and cost-optimised living space’. MPH AG can also systematically benefit from the positive developments of the investments in the coming years," says Patrick Brenske, CEO of MPH.
About MPH Health Care AG: MPH Health Care AG is an investment company with a strategic focus on the acquisition, development and sale of companies and company shares, particularly in growth segments of the healthcare market. This includes both insurance-financed and privately financed segments. However, MPH also utilises the potential offered by high-growth and profitable sectors outside the healthcare market. Contact: Patrick Brenske, Management Board Corporate Communications E-Mail: ir@mph-ag.de
30.04.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group. |
| Language: | English |
| Company: | MPH Health Care AG |
| Grünauer Straße 5 | |
| 12557 Berlin | |
| Germany | |
| Phone: | 030 / 863 21 45 60 |
| Fax: | 030 / 863 21 45 69 |
| E-mail: | info@mph-ag.de |
| Internet: | www.mph-ag.de |
| ISIN: | DE000A289V03, DE000A289VT5 |
| WKN: | A289V0 |
| Listed: | Regulated Unofficial Market in Berlin, Dusseldorf, Frankfurt (Basic Board), Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: | 2127140 |
| End of News | EQS News Service |
|
|
2127140 30.04.2025 CET/CEST
Zur besseren Einschätzung der fundamentalen Entwicklung der jeweiligen Unternehmen bietet boersengefluester.de (BGFL) eine Übersicht mit den wesentlichen Kennzahlen zu Umsatz, Ergebnis, Cashflow und Dividende. Sämtliche Angaben werden manuell in unserer Datenbank erfasst – Quelle sind die jeweiligen Geschäftsberichte. Sofern es sich um Schätzungen für künftige Zahlen handelt, stammen sie durchweg von BGFL.
| Die wichtigsten Finanzdaten auf einen Blick | ||||||||
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025e | 2026e | ||
| Umsatzerlöse1 | 3,43 | 13,55 | 30,67 | 34,46 | 65,37 | 0,00 | 0,00 | |
| EBITDA1,2 | -70,99 | -9,05 | 29,59 | 29,54 | 32,99 | 0,00 | 0,00 | |
| EBITDA-Marge3 | -2.069,68 | -66,79 | 96,48 | 85,72 | 50,47 | 0,00 | 0,00 | |
| EBIT1,4 | -71,02 | -9,07 | 29,56 | 30,21 | 32,96 | 0,00 | 0,00 | |
| EBIT-Marge5 | -2.070,55 | -66,94 | 96,38 | 87,67 | 50,42 | 0,00 | 0,00 | |
| Jahresüberschuss1 | -70,38 | -8,96 | 29,11 | 29,54 | 32,04 | 0,00 | 0,00 | |
| Netto-Marge6 | -2.051,90 | -66,13 | 94,91 | 85,72 | 49,01 | 0,00 | 0,00 | |
| Cashflow1,7 | -2,89 | -1,09 | 0,01 | -2,02 | 1,83 | 0,00 | 0,00 | |
| Ergebnis je Aktie8 | -16,44 | -2,09 | 6,80 | 6,90 | 7,48 | -6,90 | 2,00 | |
| Dividende8 | 0,00 | 0,00 | 0,00 | 1,20 | 1,20 | 1,20 | 0,60 | |
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de
Wirtschaftsprüfer: wetreu NTRG
Alle relevanten Bewertungskennzahlen, Termine und sonstige Investor-Informationen zu Ihrer Aktie kompakt zusammengefasst. Gut zu wissen: Sämtliche Daten stammen von boersengefluester.de werden täglich aktualisiert. Damit sind Sie immer auf dem neuen Stand. Kurze Erkärungen zu den Kennzahlen bekommen Sie, wenn Sie mit dem Cursor bzw. der Maus auf das jeweilige Feld gehen.
| INVESTOR-INFORMATIONEN | ||||||
| ©boersengefluester.de | ||||||
| MPH Health Care | ||||||
| WKN | ISIN | Rechtsform | Börsenwert | IPO | Einschätzung | Plus Code |
| A289V0 | DE000A289V03 | AG | 100,61 Mio € | 01.09.2009 | Kaufen | 9F4MCHV9+6R |
| KGV 2027e | KGV 10Y-Ø | BGFL-Ratio | Shiller-KGV | KBV | KCV | KUV |
| 7,46 | 6,28 | 1,19 | 5,40 | 0,37 | 55,01 | 1,54 |
|
Dividende '2023 in € |
Dividende '2024 in € |
Dividende '2025e in € |
Div.-Rendite '2025e in % |
| 1,20 | 1,20 | 1,20 | 4,98% |
| Hauptversammlung | Q1-Zahlen | Q2-Zahlen | Q3-Zahlen | Bilanz-PK |
| 17.07.2025 | 12.06.2025 | 16.09.2025 | 20.11.2025 | 28.05.2025 |
| Abstand 60-Tage-Linie | Abstand 200-Tage-Linie | Performance YtD | Kursveränderung 52 Wochen | IPO |
| +7,49% | +14,93% | +9,55% | +2,12% | +0,00% |
Auf dem 2013 von Gereon Kruse gegründeten Finanzportal boersengefluester.de dreht sich alles um deutsche Aktien – mit klarem Schwerpunkt auf Nebenwerte. Neben klassischen redaktionellen Beiträgen sticht die Seite insbesondere durch eine Vielzahl an selbst entwickelten Analysetools hervor. Basis sämtlicher Tools ist eine komplett selbst gepflegte Datenbank für mehr als 650 Aktien. Damit erstellt boersengefluester.de Deutschlands größte Gewinn- und Dividendenprognose.